BONE BIOLOGICS CORP's ticker is and the CUSIP is 098070113. A total of 6 filers reported holding BONE BIOLOGICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,299 | +127.2% | 107,476 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,892 | -79.0% | 107,476 | -0.9% | 0.00% | -81.8% |
| Q3 2022 | $9,000 | -43.8% | 108,476 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $16,000 | -56.8% | 108,476 | 0.0% | 0.01% | +83.3% |
| Q1 2022 | $37,000 | -68.1% | 108,476 | -34.4% | 0.01% | -64.7% |
| Q4 2021 | $116,000 | – | 165,476 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 140,471 | $48,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 108,476 | $37,000 | 0.01% |
| CLEAR STREET LLC | 20,000 | $7,000 | 0.00% |
| Warberg Asset Management LLC | 219,134 | $76,000 | 0.00% |
| UBS Group AG | 10,893 | $4,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |